Rónán C. O’Hagan

4.8k total citations · 1 hit paper
30 papers, 3.1k citations indexed

About

Rónán C. O’Hagan is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Rónán C. O’Hagan has authored 30 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Rónán C. O’Hagan's work include Ubiquitin and proteasome pathways (5 papers), Cancer-related Molecular Pathways (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Rónán C. O’Hagan is often cited by papers focused on Ubiquitin and proteasome pathways (5 papers), Cancer-related Molecular Pathways (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Rónán C. O’Hagan collaborates with scholars based in United States, Canada and Brazil. Rónán C. O’Hagan's co-authors include Ronald A. DePinho, Lynda Chin, Frederick W. Alt, Ignacio Moreno de Alborán, Barbara A. Malynn, Laurie A. Davidson, John A. Hassell, James W. Horner, Carlos Cordon-Cardo and George D. Yancopoulos and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Genetics.

In The Last Decade

Rónán C. O’Hagan

29 papers receiving 3.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Essential role for oncogenic Ras in tumour maintenance

1999 697 citations Lynda Chin, Jason H. Pomerantz et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rónán C. O’Hagan United States	18	2.2k	1.1k	458	410	327	30	3.1k
Frederic Tort Spain	19	2.6k 1.1×	1.3k 1.2×	550 1.2×	243 0.6×	258 0.8×	38	3.4k
Mario Cioce Italy	21	2.6k 1.2×	706 0.6×	426 0.9×	301 0.7×	315 1.0×	34	3.3k
Juan Martín‐Caballero Spain	29	1.9k 0.9×	1.4k 1.3×	376 0.8×	614 1.5×	158 0.5×	43	3.0k
Angelo Cicalese Italy	9	2.0k 0.9×	1.1k 1.0×	484 1.1×	663 1.6×	148 0.5×	10	2.7k
Kim L. Mercer United States	10	2.6k 1.2×	1.6k 1.5×	737 1.6×	266 0.6×	335 1.0×	15	3.9k
Sara Piccinin Italy	22	2.3k 1.0×	1.4k 1.3×	628 1.4×	676 1.6×	234 0.7×	29	3.4k
Jacqueline J.L. Jacobs Netherlands	24	4.2k 1.9×	1.5k 1.3×	580 1.3×	814 2.0×	428 1.3×	41	5.0k
David Dankort Canada	25	2.6k 1.2×	2.0k 1.8×	581 1.3×	241 0.6×	254 0.8×	39	3.9k
Igor Garkavtsev United States	25	2.9k 1.3×	1.2k 1.1×	1.2k 2.5×	376 0.9×	194 0.6×	32	4.1k
Purificacı́on Muñoz Spain	29	2.5k 1.1×	1.1k 1.0×	755 1.6×	1.2k 3.0×	263 0.8×	35	3.8k

Countries citing papers authored by Rónán C. O’Hagan

Since Specialization

Citations

This map shows the geographic impact of Rónán C. O’Hagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rónán C. O’Hagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rónán C. O’Hagan more than expected).

Fields of papers citing papers by Rónán C. O’Hagan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rónán C. O’Hagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rónán C. O’Hagan. The network helps show where Rónán C. O’Hagan may publish in the future.

Co-authorship network of co-authors of Rónán C. O’Hagan

This figure shows the co-authorship network connecting the top 25 collaborators of Rónán C. O’Hagan. A scholar is included among the top collaborators of Rónán C. O’Hagan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rónán C. O’Hagan. Rónán C. O’Hagan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Park, Miso, Magali Pederzoli-Ribeil, Uğur Eskiocak, et al.. (2023). XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer. Journal for ImmunoTherapy of Cancer. 11(12). e007785–e007785. 8 indexed citations

Berk, Alexandra, Lynda Chin, Stacie Hudgens, et al.. (2023). A Study Design to Harmonize Patient-Reported Outcomes Across Data Sets. JCO Clinical Cancer Informatics. 7(7). e2200161–e2200161. 3 indexed citations

O’Neil, Jennifer, Manoussa Fanny, Justin Greene, et al.. (2021). Tumor-selective activity of XTX202, a protein-engineered IL-2, in mice without peripheral toxicities in nonhuman primates.. Journal of Clinical Oncology. 39(15_suppl). 2563–2563. 15 indexed citations

Zhang, Minjie, Uğur Eskiocak, M. A. McLaughlin, et al.. (2020). 587 Tumor-activated Fc-engineered anti-CTLA-4 monoclonal antibody, XTX101, demonstrates tumor-selective PD and efficacy in preclinical models. SHILAP Revista de lepidopterología. A351.2–A351. 2 indexed citations

Celano, Stephanie L., Lisette Yco, Hakan Günaydin, et al.. (2019). Identification of Kinases Responsible for p53-Dependent Autophagy. iScience. 15. 109–118. 4 indexed citations

Martin, Katie R., Stephanie L. Celano, Hakan Günaydin, et al.. (2018). A Potent and Selective ULK1 Inhibitor Suppresses Autophagy and Sensitizes Cancer Cells to Nutrient Stress. iScience. 8. 74–84. 139 indexed citations

Proia, Theresa A., Feng Jiang, Richard Nicoletti, et al.. (2015). 23814, an Inhibitory Antibody of Ligand-Mediated Notch1 Activation, Modulates Angiogenesis and Inhibits Tumor Growth without Gastrointestinal Toxicity. Molecular Cancer Therapeutics. 14(8). 1858–1867. 8 indexed citations

Williams, Sybil M. Genther, Paula B. Andrade, Brian Dolinski, et al.. (2015). Treatment with the PARP inhibitor, niraparib, sensitizes colorectal cancer cell lines to irinotecan regardless of MSI/MSS status. Cancer Cell International. 15(1). 14–14. 31 indexed citations

Kannan, Karuppiah, Norman E. Sharpless, Jin Xu, et al.. (2003). Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model. Proceedings of the National Academy of Sciences. 100(3). 1221–1225. 90 indexed citations

10.

O’Hagan, Rónán C., Sandy Chang, Richard S. Maser, et al.. (2002). Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell. 2(2). 149–155. 182 indexed citations

11.

Sharpless, Norman E., David O. Ferguson, Rónán C. O’Hagan, et al.. (2001). Impaired Nonhomologous End-Joining Provokes Soft Tissue Sarcomas Harboring Chromosomal Translocations, Amplifications, and Deletions. Molecular Cell. 8(6). 1187–1196. 133 indexed citations

12.

Alborán, Ignacio Moreno de, Rónán C. O’Hagan, Fátima Gärtner, et al.. (2001). Analysis of C-MYC Function in Normal Cells via Conditional Gene-Targeted Mutation. Immunity. 14(1). 45–55. 319 indexed citations

13.

O’Hagan, Rónán C., Nicole Schreiber‐Agus, Ken Chen, et al.. (2000). Gene-target recognition among members of the Myc superfamily and implications for oncogenesis. Nature Genetics. 24(2). 113–119. 120 indexed citations

14.

O’Hagan, Rónán C., Michael Ohh, Gregory David, et al.. (2000). Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression. Genes & Development. 14(17). 2185–2191. 163 indexed citations

15.

O’Hagan, Rónán C., Richard Tozer, Marc Symons, Frank McCormick, & John A. Hassell. (2000). Guest Editor. Oncogene. 19(56). 6549–6549. 1 indexed citations

16.

Chin, Lynda, Jason H. Pomerantz, Michelle Wong, et al.. (1999). Essential role for oncogenic Ras in tumour maintenance. Nature. 400(6743). 468–472. 697 indexed citations breakdown →

17.

Greenberg, Roger A., Rónán C. O’Hagan, Hongyu Deng, et al.. (1999). Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene. 18(5). 1219–1226. 344 indexed citations

18.

O’Hagan, Rónán C. & John A. Hassell. (1998). The PEA3 Ets transcription factor is a downstream target of the HER2/Neu receptor tyrosine kinase. Oncogene. 16(3). 301–310. 62 indexed citations

19.

Benz, Christopher C., Rónán C. O’Hagan, B. Diane Richter, et al.. (1997). HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer. Oncogene. 15(13). 1513–1525. 142 indexed citations

20.

O’Hagan, Rónán C., Richard Tozer, Marc Symons, Frank McCormick, & John A. Hassell. (1996). The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades.. PubMed. 13(6). 1323–33. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact